Projects that will be considered for Pfizer support will focus on preparing and/or optimizing multidisciplinary care teams for the integration of gene therapy into the treatment armamentarium for patients with a Rare Disease.

Support is available for the development of leadership, best practices, SOP development, site readiness, support and/or training of HCPs within a multidisciplinary team environment to optimize the quality of care for patients who have/will have gene therapy in their treatment armamentarium.

Projects that address recombinant adeno-associated virus gene therapy in Rare Disease and are therapeutic area and disease area agnostic (i.e., platform) will be prioritized

It is not our intent to support clinical research projects. Projects evaluating the efficacy of therapeutic or diagnostic agents will not be considered.

Individual projects requesting up to $50,000 will be considered. The estimated total available budget related to this RFP is $150,000

Members of multidisciplinary care teams for gene therapy including but not limited to Medical Geneticists, Genetic Counsellors, Pharmacists, and Specialist Nurses.

Please go to www.cybergrants.com/pfizer/QI and sign in.

First-time users should click "Create your password".

In the application: o For the question "Are you replying to a Request for Proposal as part of the Competitive Grant Program?" select Yes o Select the following Competitive Grant Program Name: 2021 RD GQI Delivery of Gene Therapies to Patients with Rare Diseases

Requirements for submission: Complete all required sections of the online application and upload your project proposal (see Appendix) in the Full Proposal Submission field.

If you encounter any technical difficulties with the website, please click the "Technical Questions" link at the bottom of the page.

In case of interest, contact with FSJD Research Dpt. before 25^th May.